Naturl Alt Intl Stock Price, News & Analysis

Natural Alternatives International, Inc. (NAI) will release its first quarter 2022 financial results on November 9, 2021, after market close. The company's operations include the formulation and marketing of customized nutritional supplements and strategic partnerships. A comprehensive investor presentation will be available following the earnings release. The press release includes forward-looking statements and cautions about potential risks and uncertainties affecting future financial performance. Further details can be found on NAI's website.

Natural Alternatives International (NAII) is participating in SupplySide West on October 27-28, 2021, at booth #5472. The company specializes in customized nutritional supplement manufacturing, featuring patented products like CarnoSyn® and SR CarnoSyn® beta-alanine. NAII aims to support consumer health and wellness through innovative formulations. Additionally, NAII recently became the first to meet the new standards set by the Supplement Safety & Compliance Initiative (SSCI) and expanded its manufacturing capabilities in Carlsbad, CA.

Natural Alternatives International (NAII) reported a strong fiscal Q4 2021, posting a net income of $3.0 million, or $0.47 per diluted share, on sales of $44.4 million, a 26.5% increase from the previous year. Annual net income for FY 2021 reached $10.8 million, with sales up 50.2% to $178.5 million. Private-label contract manufacturing sales rose by 54.6%, attributed to increased demand for immune products during the pandemic. Anticipating a 5-10% sales increase for FY 2022, NAII expects initial challenges in the first half due to supply chain issues, but positive growth is anticipated in the latter half.

Natural Alternatives International, Inc. (NAII) has acquired a 54,154 ft² manufacturing and warehouse facility in Carlsbad, CA, for $17.5 million, with $10 million financed through a term loan and $7.5 million in cash. This facility will be retrofitted for high-volume powder blending and packaging, enhancing raw material storage capacity to support projected domestic sales growth. CEO Mark A. Le Doux emphasized the strategic importance of this investment, as it aims to improve production capabilities and expand customer service in the growing powder packaged delivery segment.

Natural Alternatives International, Inc. (NAII) has secured a new credit facility with Wells Fargo Bank, increasing its borrowing capacity from $10 million to $20 million. This facility will support ongoing working capital and potential future acquisitions, with a maturity date extended to May 24, 2024. CEO Mark A. Le Doux emphasized the importance of this facility in strengthening NAII's financial position, enabling the company to pursue growth opportunities. The enhanced financial capability reflects NAII's solid balance sheet and successful operations.

Natural Alternatives International (NAII) reported a net income of $1.9 million ($0.30 per diluted share) for Q3 FY2021, reversing a net loss of $4.0 million in Q3 FY2020. Net sales surged 81.8% to $46.3 million, boosted by a significant increase in private-label contract manufacturing sales, which grew 86.2%. For the nine months ending March 31, 2021, net income was $7.8 million compared to a loss of $3.4 million in the previous year. The company expects annualized FY2021 net sales to rise by 45% to 55%, while also maintaining strong cash reserves of $28.1 million.

Natural Alternatives International, Inc. (NAII) has announced a $3.0 million increase to its stock repurchase plan, raising the total authorization to $15.0 million. This plan allows for the repurchase of shares based on market conditions, with 1.6 million shares already acquired. After this increase, $3.2 million remains available for further repurchases. The company's stock buyback strategy aims to enhance shareholder value amid ongoing market dynamics.

Natural Alternatives International, Inc. (NAII) has released an investor presentation aimed at enhancing communication with current and potential shareholders. The presentation is part of a broader initiative to articulate the company's long-term direction and management goals. CEO Mark A. Le Doux highlighted the firm’s plans to engage more with institutional investors and participate in conferences, signaling optimism about upcoming opportunities in their pipeline. The presentation is accessible on their investor relations webpage.

Natural Alternatives International (NAII) reported a significant increase in net income to $3.6 million ($0.57/share) for Q2 FY2021, a notable rise from $0.5 million ($0.07/share) last year. Net sales reached $48.1 million, up 65.2% from $29.1 million. Private-label contract manufacturing soared by 82.5%, whereas CarnoSyn® sales dropped 35.5%, impacted by competition and COVID-19. Year-to-date income stands at $5.9 million ($0.91/share), with expectations of 30% to 50% sales growth for FY2021 and operating income between 5% and 7%. Cash as of December 31, 2020, was $28.6 million.